NKG2 Antibodies

Santa Cruz Biotechnology features a diverse variety of NKG2 monoclonal antibodies for research in immune response and cellular interactions. NKG2 monoclonal antibodies are compatible with multiple experimental applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NKG2 proteins regulate immune responses, particularly in the recognition and elimination of stressed or infected cells. Natural killer (NK) cells and T cells require NKG2 proteins for activation, which strengthens the body's defense against tumors and viral infections. Research focused on NKG2 proteins advances the development of therapeutic strategies in cancer immunotherapy and infectious disease management. Scientists investigating immune system regulation can utilize NKG2 monoclonal antibodies to explore cellular pathways and mechanisms. Understanding NKG2 protein function helps reveal the complexities of immune cell communication and activation. NKG2 monoclonal antibodies enable detailed examination of protein expression patterns and interactions in various cell types. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge and developing innovative therapeutic approaches in immunology.